港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

科倫博泰生物-B

285.400

-3.600-1.25%

成交量：81.19萬

成交額：2.33億

市值：647.86億

市盈率：-223.03

高：294.000

開：285.000

低：275.000

收：289.000

資料載入中...

總覽公司新聞公告

科倫博泰生物-B(06990)發佈2024年度業績，淨虧損2.67億元，同比收窄53.5%

科倫博泰生物-B(06990)擬選舉葛均友為執行董事

科倫博泰生物-B03月21日主力淨流出357萬元散戶資金買入

科倫博泰生物-B訂立多份結構性存款協議

格隆汇资讯

科倫博泰生物-B(06990)認購結構性存款

科倫博泰生物-B03月20日主力淨流入106萬元散戶資金拋售

科倫博泰生物-B03月18日獲主力加倉1417萬元

科倫博泰生物-B03月17日主力淨流入100萬元散戶資金拋售

高盛：給予科倫博泰生物-B(06990)“買入”評級目標價為239.14港元

醫藥股繼續走強藥明生物(02269)漲7.73% 國家醫保局為腦機接口醫療服務價格單獨立項

科倫博泰生物-B盤中異動早盤快速拉昇5.04%

科倫博泰生物-B(6990.HK)：SKB264EGFRM肺癌順利獲批 25年有望加速放量

中信建投证券

科倫博泰生物-B03月13日主力淨流入499萬元散戶資金拋售

科倫博泰生物-B盤中漲超5% TROP2 ADC蘆康沙妥珠單抗第二項適應症獲批上市

科倫博泰生物-B盤中異動快速跳水5.07%

科倫博泰生物-B03月11日主力淨流出737萬元散户資金買入

《股市簡訊》科倫博泰生物漲2.2%，核心產品在中國獲批第二個適應症

科倫博泰生物-B盤中異動早盤快速下挫5.77%

智通港股早知道 | 納指暴跌4% 廣東組織開展“機器人+”行動

科倫博泰生物核心產品獲批新增適應症

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06990/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科倫博泰生物-B","latestPrice":285.4,"timestamp":1744877289037,"preClose":289,"halted":0,"volume":811904,"delay":0,"floatShares":131000000,"shares":227000000,"eps":-1.2796556756154556,"marketStatus":"休市中","change":-3.6,"latestTime":"04-17 16:08:09","open":285,"high":294,"low":275,"amount":232778521,"amplitude":0.065744,"askPrice":286.4,"askSize":300,"bidPrice":285.4,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-1.2796556756154556,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":289,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":1.0355934219983844,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":131000000,"roa":"-3.41%","roe":"-9.46%","lyrEps":-1.279656,"volumeRatio":1.0355934219983844,"shares":227000000,"dividePrice":0,"high":294,"amplitude":0.065744,"preClose":289,"low":275,"week52Low":120.2,"pbRate":"18.42","psRate":"31.52","week52High":346,"institutionHeld":0,"latestPrice":285.4,"eps":-1.2796556756154556,"divideRate":0,"volume":811904,"delay":0,"ttmEps":-1.2796556756154556,"open":285,"prevYearClose":163.3,"prevWeekClose":302,"prevMonthClose":290.8,"prevQuarterClose":290.8,"fiveDayClose":280.8,"twentyDayClose":259.4,"sixtyDayClose":162.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521744094","title":"科倫博泰生物-B(06990)發佈2024年度業績，淨虧損2.67億元，同比收窄53.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2521744094","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521744094?lang=zh_tw&edition=fundamental","pubTime":"2025-03-24 19:42","pubTimestamp":1742816527,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B(06990)发布截至2024年12月31日止年度业绩，收入19.33亿元(人民币，下同)，同比增长25.5%;净亏损2.67亿元，同比收窄53.5%;每股基本亏损1.20元。集团2024年年度的收入同比增加，乃主要由于2024达成多个研发里程碑;及2024年开始药品销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1266601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2521115741","title":"科倫博泰生物-B(06990)擬選舉葛均友為執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2521115741","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521115741?lang=zh_tw&edition=fundamental","pubTime":"2025-03-24 19:28","pubTimestamp":1742815700,"startTime":"0","endTime":"0","summary":"公司现任执行董事葛均友博士拟由公司职工以民主方式选举为第四届董事会职工代表董事，惟须经股东通过决议案批准建议修改章程以设立职工代表董事的角色，及公司职工于职工代表大会预期将与即将召开的年度股东大会同期举行上选举葛均友博士为职工代表董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1266588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2521547272","title":"科倫博泰生物-B03月21日主力淨流出357萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2521547272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521547272?lang=zh_tw&edition=fundamental","pubTime":"2025-03-21 16:17","pubTimestamp":1742545056,"startTime":"0","endTime":"0","summary":"03月21日, 科伦博泰生物-B股价跌1.59%，报收260.00元，成交金额2.07亿元，换手率0.61%，振幅6.89%，量比2.47。科伦博泰生物-B今日主力资金净流出357万元，上一交易日主力净流入106万元。该股近5个交易日上涨4.89%，主力资金累计净流入700万元；近20日主力资金累计净流出6296万元，其中净流出天数为12日。该股主力净额占比0.01%，港股市场排名2261/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250321171038a69eb181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250321171038a69eb181&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2520468603","title":"科倫博泰生物-B訂立多份結構性存款協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2520468603","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520468603?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 22:41","pubTimestamp":1742481680,"startTime":"0","endTime":"0","summary":"同日，公司订立招商银行结构性存款协议II，据此，公司同意向招商银行认购一笔结构性存款，本金额为人民币200百万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032022412494bb3edc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032022412494bb3edc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2520468691","title":"科倫博泰生物-B(06990)認購結構性存款","url":"https://stock-news.laohu8.com/highlight/detail?id=2520468691","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520468691?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 22:39","pubTimestamp":1742481597,"startTime":"0","endTime":"0","summary":"于2025年3月20日，公司订立成都银行结构性存款协议IV，据此，公司同意向成都银行认购一笔结构性存款，本金额为人民币1亿元。于本公告日期，存置于招商银行的结构性存款的未偿还本金总额为人民币4亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1265102.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2520435606","title":"科倫博泰生物-B03月20日主力淨流入106萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2520435606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520435606?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 16:16","pubTimestamp":1742458616,"startTime":"0","endTime":"0","summary":"03月20日, 科伦博泰生物-B股价涨1.85%，报收264.20元，成交金额9997万元，换手率0.29%，振幅3.55%，量比1.01。科伦博泰生物-B今日主力资金净流入106万元，上一交易日主力净流出568万元。该股近5个交易日上涨11.51%，主力资金累计净流入728万元；近20日主力资金累计净流出4867万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320165754a43b0eaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320165754a43b0eaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2520614266","title":"科倫博泰生物-B03月18日獲主力加倉1417萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2520614266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520614266?lang=zh_tw&edition=fundamental","pubTime":"2025-03-18 16:17","pubTimestamp":1742285861,"startTime":"0","endTime":"0","summary":"03月18日, 科伦博泰生物-B股价涨2.88%，报收257.20元，成交金额8288万元，换手率0.25%，振幅5.04%，量比0.55。科伦博泰生物-B今日主力资金净流入1417万元，上一交易日主力净流入100万元。该股近5个交易日上涨5.64%，主力资金累计净流入1051万元；近20日主力资金累计净流出5441万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318170047a437fb07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318170047a437fb07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2520549894","title":"科倫博泰生物-B03月17日主力淨流入100萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2520549894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520549894?lang=zh_tw&edition=fundamental","pubTime":"2025-03-17 16:16","pubTimestamp":1742199419,"startTime":"0","endTime":"0","summary":"03月17日, 科伦博泰生物-B股价涨0.16%，报收250.00元，成交金额4601万元，换手率0.14%，振幅3.04%，量比0.29。科伦博泰生物-B今日主力资金净流入100万元，上一交易日主力净流出329万元。该股近5个交易日上涨2.28%，主力资金累计净流出1103万元；近20日主力资金累计净流出6933万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250317165544a1e06267&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250317165544a1e06267&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2519153278","title":"高盛：給予科倫博泰生物-B(06990)“買入”評級 目標價為239.14港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2519153278","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519153278?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 10:13","pubTimestamp":1741918438,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，高盛发布研报称，对科伦博泰生物-B给予“买入”评级，基于风险调整后的现金流折现方法得出的12个月目标价为239.14港元，假设条件为：1)11%的折现率;2)3%的终值增长率;3)基于行业不同阶段平均成功率并根据现有临床数据进行调整的成功概率。该行认为科伦博泰有望成为一家有意义的全球ADC领域参与者，专注于为全球患者开发差异化的抗体偶联药物并实现商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1261798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990"],"gpt_icon":0},{"id":"2519180728","title":"醫藥股繼續走強 藥明生物(02269)漲7.73% 國家醫保局為腦機接口醫療服務價格單獨立項","url":"https://stock-news.laohu8.com/highlight/detail?id=2519180728","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519180728?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 09:58","pubTimestamp":1741917523,"startTime":"0","endTime":"0","summary":"根据麦肯锡估算，预计在2030—2040年间，全球脑机接口在医疗领域应用的潜在市场规模有望达到400亿—1450亿美元，其中严肃医疗应用的潜在市场规模介于150亿—850亿美元，而消费医疗应用的潜在市场规模介于250亿—600亿美元。另外，近期多家医药头部企业宣布接入AI大模型，医药行业有望迎来新机遇。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1955039","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","LU0979878070.USD","LU0823426480.USD","LU1242518857.USD","BK1610","00853","LU0359202008.SGD","09939","02268","LU0516423091.SGD","LU0572944931.SGD","BK1576","02252","LU1880383366.USD","02269","159938","LU0196878994.USD","LU2125910500.SGD","LU0307460666.USD","SG9999002562.SGD","02359","LU0326950275.SGD","LU0588546209.SGD","BK1515","LU0348825331.USD","BK1597","BK1100","BK1161","LU0456827905.SGD","LU0348735423.USD","LU0456846285.SGD","03933","LU0819121731.USD","BK1585","06990","BK1617","02172","LU0039217434.USD","01951","BK1589","LU0051755006.USD","LU0708995583.HKD","LU0320764599.SGD","LU0516423174.USD","LU1688375341.USD","02563","LU0856984785.SGD","01302","LU0359201612.USD","BK1574"],"gpt_icon":0},{"id":"2519813522","title":"科倫博泰生物-B盤中異動 早盤快速拉昇5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2519813522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519813522?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 09:54","pubTimestamp":1741917244,"startTime":"0","endTime":"0","summary":"2025年03月14日早盘09时54分，科伦博泰生物-B股票出现波动，股价大幅拉升5.04%。截至发稿，该股报250.000港元/股，成交量14.63万股，换手率0.11%，振幅7.56%。科伦博泰生物-B股票所在的生物技术行业中，整体涨幅为0.53%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314095404964498e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314095404964498e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2519680039","title":"科倫博泰生物-B(6990.HK)：SKB264EGFRM肺癌順利獲批 25年有望加速放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2519680039","media":"中信建投证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519680039?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 00:00","pubTimestamp":1741881600,"startTime":"0","endTime":"0","summary":"这也使得SKB264 成为全球首个在肺癌适应症获批上市的TROP2 ADC 药物。2022 年5 月，公司与默沙东首次达成协议，授权其SKB264 海外权益，公司获得共1.02 亿美元一次性付款及潜在11.6 亿美元的里程碑付款。A167 1L 治疗NPC 的NDA 于2024 年5 月获CDE 受理，25 年1 月获批上市，两款产品均顺利进入商业化阶段，25 年有望持续放量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314205156a1dcd19d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314205156a1dcd19d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2519238881","title":"科倫博泰生物-B03月13日主力淨流入499萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2519238881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519238881?lang=zh_tw&edition=fundamental","pubTime":"2025-03-13 16:44","pubTimestamp":1741855441,"startTime":"0","endTime":"0","summary":"03月13日, 科伦博泰生物-B股价涨1.54%，报收238.00元，成交金额1.54亿元，换手率0.48%，振幅9.22%，量比1.05。科伦博泰生物-B今日主力资金净流入499万元，上一交易日主力净流出637万元。该股近5个交易日下跌6.20%，主力资金累计净流出693万元；近20日主力资金累计净流出5627万元，其中净流出天数为12日。该股主力净额占比0.02%，港股市场排名195/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250313180245ab63be68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250313180245ab63be68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2519076506","title":"科倫博泰生物-B盤中漲超5% TROP2 ADC蘆康沙妥珠單抗第二項適應症獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2519076506","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519076506?lang=zh_tw&edition=fundamental","pubTime":"2025-03-13 11:40","pubTimestamp":1741837200,"startTime":"0","endTime":"0","summary":"　　科伦博泰生物-B盘中涨超5%，截至发稿，股价上涨3.24%，现报242港元，成交额9741.92万港元。　　科伦博泰生物近日公布，公司靶向人滋养细胞表面抗原2的抗体药物偶联物芦康沙妥珠单抗（佳泰莱）获国家药品监督管理局批准第二个适应症，用于治疗经表皮生长因子受体酪氨酸激酶抑制剂和含铂化疗治疗后进展的EGFR基因突变阳性的局部晚期或转移性非鳞状非小细胞肺癌成人患者。这是全球首个在肺癌适应症获批上市的TROP2ADC药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-13/doc-inepnpwr0866652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0196878994.USD","BK4231","BK1161","ADC","06990","BK4080"],"gpt_icon":0},{"id":"2518055394","title":"科倫博泰生物-B盤中異動 快速跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518055394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518055394?lang=zh_tw&edition=fundamental","pubTime":"2025-03-12 14:46","pubTimestamp":1741762005,"startTime":"0","endTime":"0","summary":"2025年03月12日下午盘14时46分，科伦博泰生物-B股票出现异动，股价大幅下跌5.07%。截至发稿，该股报232.400港元/股，成交量50.34万股，换手率0.38%，振幅7.11%。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。科伦博泰生物-B股票所在的生物技术行业中，整体跌幅为0.79%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031214464596423d48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031214464596423d48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2518718198","title":"科倫博泰生物-B03月11日主力淨流出737萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2518718198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518718198?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 16:16","pubTimestamp":1741681002,"startTime":"0","endTime":"0","summary":"03月11日, 科伦博泰生物-B股价跌0.49%，报收244.80元，成交金额1.83亿元，换手率0.57%，振幅7.97%，量比1.45。科伦博泰生物-B今日主力资金净流出737万元，上一交易日主力净流入115万元。该股近5个交易日上涨3.99%，主力资金累计净流出2153万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出5883万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170119abf60a77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170119abf60a77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2518832737","title":"《股市簡訊》科倫博泰生物漲2.2%，核心產品在中國獲批第二個適應症","url":"https://stock-news.laohu8.com/highlight/detail?id=2518832737","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518832737?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 10:23","pubTimestamp":1741659803,"startTime":"0","endTime":"0","summary":"《股市简讯》科伦博泰生物涨2.2%，核心产品在中国获批第二个适应症* 中国生物科技公司--科伦博泰生物6990.HK周二早盘低开1.3%后转升最多2.2%。* 该公司此前公告称，核心产品芦康沙妥珠单抗获国家药品监督管理局批准第二个适应症，用于治疗经表皮生长因子受体酪氨酸激酶抑制剂和含铂化疗治疗后进展的EGFR基因突变阳性的局部晚期或转移性非鳞状非小细胞肺癌成人患者。* 科伦博泰生物今年迄今大涨50.8%，同期恒生指数.HSI大幅上扬18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL4S3PU071:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2518731401","title":"科倫博泰生物-B盤中異動 早盤快速下挫5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518731401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518731401?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 09:30","pubTimestamp":1741656640,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘09时30分，科伦博泰生物-B股票出现异动，股价急速下跌5.77%。科伦博泰生物-B股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，荃信生物-B、东曜药业-B、百济神州涨幅较大，振幅较大的相关个股有方达控股、科伦博泰生物-B、基石药业-B，振幅分别为7.69%、6.59%、6.02%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110930409640c947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110930409640c947&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2518787467","title":"智通港股早知道 | 納指暴跌4% 廣東組織開展“機器人+”行動","url":"https://stock-news.laohu8.com/highlight/detail?id=2518787467","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518787467?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 07:28","pubTimestamp":1741649328,"startTime":"0","endTime":"0","summary":"组织开展“机器人+”行动，围绕工业、农业、城市管理、医疗、养老服务、特种作业等领域，深入挖掘开放应用场景。此次钴价异动与刚果调整出口政策密切相关，并对国内钴酸锂、硫酸钴与电池回收等细分行业，以及相关上市公司的经营层面构成显著影响。根据公司的组织章程细则，毋须再召开股东大会以批准转换及上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1604","HSCEI","BK4561","09922","NQmain","USJW.SI","NVIW.SI","BK1178","LU0196878994.USD","BK1589","MNQmain","IE0034224299.USD","00866",".IXIC","TSYW.SI","HSTECH","BK1233","BK4550","BK1147","TQQQ","BK4593","159659","QLD","BK4534","USAW.SI","YANG","PSQ","QID","SQQQ","BK4585","BK4581","BK1161","BK4588","BK1591","06990","03086","BK4614"],"gpt_icon":1},{"id":"2518319245","title":"科倫博泰生物核心產品獲批新增適應症","url":"https://stock-news.laohu8.com/highlight/detail?id=2518319245","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518319245?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 17:55","pubTimestamp":1741600521,"startTime":"0","endTime":"0","summary":"3月10日，科伦博泰生物-B（06990）发布公告，公司的核心产品芦康沙妥珠单抗（sac-TMT）近日获得国家药品监督管理局批准，新增适应症用于EGFR突变非小细胞肺癌的治疗。这一批准使得芦康沙妥珠单抗成为全球首个在肺癌适应症获批上市的TROP2抗体药物偶联物（ADC），标志着公司在抗癌药物领域的重要进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503103341366183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06990","BK4080","BK4231","ADC","BK1161","LU0196878994.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盤後","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-28","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2941,"buy":0.7059,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7059,"analysts":17,"updateTime":1744646400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2025-04-17","current":-228.611836,"percent":0.03653,"low":-257.850518,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"high":-21.029201,"avg":-97.473315,"sd":62.021902,"marketCap":64862287200},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200}],"updateTime":1745156687961}}}